|
1
|
Imura S, Shimada M, Utsunomiya T, et al:
Impact of splenectomy in patients with liver cirrhosis: Results
from 18 patients in a single center experience. Hepatol Res.
40:894–900. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ito K, Ozasa H, Noda Y and Horikawa S:
Splenic artery ligation ameliorates hepatic ischemia and
reperfusion injury in rats. Liver Int. 26:254–260. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ito K, Ozasa H and Horikawa S: Effects of
prior splenectomy on remnant liver after partial hepatectomy with
Pringle maneuver in rats. Liver Int. 25:438–444. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shimada M, Ijichi H, Yonemura Y, et al:
The impact of splenectomy or splenic artery ligation on the outcome
of a living donor adult liver transplantation using a left lobe
graft. Hepatogastroenterology. 51:625–629. 2004.PubMed/NCBI
|
|
5
|
Chen XP, Wu ZD, Huang ZY and Qiu FZ: Use
of hepatectomy and splenectomy to treat hepatocellular carcinoma
with cirrhotic hypersplenism. Br J Surg. 92:334–339. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Uehara H, Akahoshi T, Kawanaka H, et al:
Endothelin-1 derived from spleen-activated Rho-kinase pathway in
rats with secondary biliary cirrhosis. Hepatol Res. 42:1039–1047.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Arakawa Y, Shimada M, Uchiyama H, et al:
Beneficial effects of splenectomy on massive hepatectomy model in
rats. Hepatol Res. 39:391–397. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ito K, Ozasa H, Yoneya R and Horikawa S:
Splenectomy ameliorates hepatic ischemia and reperfusion injury
mediated by heme oxygenase-1 induction in the rat. Liver.
22:467–473. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tarquini R, Masini E, La Villa G, et al:
Increased plasma carbon monoxide in patients with viral cirrhosis
and hyperdynamic circulation. Am J Gastroenterol. 104:891–897.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Duan ZJ, Yang D, Wang F, Sun YJ, Sun XY
and Zheng ML: Heme oxygenase-1 regulates the major route involved
in formation of immune hepatic fibrosis in rats. Chin Med J.
123:3304–3308. 2010.PubMed/NCBI
|
|
11
|
Sass G, Barikbin R and Tiegs G: The
multiple functions of heme oxygenase-1 in the liver. Z
Gastroenterol. 50:34–40. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Naik JS, O’Donaughy TL and Walker BR:
Endogenous carbon monoxide is an endothelial-derived vasodilator
factor in the mesenteric circulation. Am J Physiol Heart Circ
Physiol. 284:H838–H845. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Guo SB, Duan ZJ, Li Q and Sun XY: Effect
of heme oxygenase-1 on renal function in rats with liver cirrhosis.
World J Gastroenterol. 17:322–328. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Guo SB, Duan ZJ, Li Q and Sun XY: Effects
of heme oxygenase-1 on pulmonary function and structure in rats
with liver cirrhosis. Chin Med J. 124:918–922. 2011.PubMed/NCBI
|
|
15
|
Iwamoto T, Terai S, Mizunaga Y, et al:
Splenectomy enhances the anti-fibrotic effect of bone marrow cell
infusion and improves liver function in cirrhotic mice and
patients. J Gastroenterol. 47:300–312. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Brown KE, Dennery PA, Ridnour LA, et al:
Effect of iron overload and dietary fat on indices of oxidative
stress and hepatic fibrogenesis in rats. Liver Int. 23:232–242.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fallon MB, Abrams GA, McGrath JW, Hou Z
and Luo B: Common bile duct ligation in the rat: a model of
intrapulmonary vasodilatation and hepatopulmonary syndrome. Am J
Physiol. 272:G779–G784. 1997.PubMed/NCBI
|
|
18
|
Luo B, Abrams GA and Fallon MB:
Endothelin-1 in the rat bile duct ligation model of hepatopulmonary
syndrome: correlation with pulmonary dysfunction. J Hepatol.
29:571–578. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shackelford C, Long G, Wolf J, Okerberg C
and Herbert R: Qualitative and quantitative analysis of
nonneoplastic lesions in toxicology studies. Toxicol Pathol.
30:93–96. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kakinuma S, Tanaka Y, Chinzei R, et al:
Human umbilical cord blood as a source of transplantable hepatic
progenitor cells. Stem Cells. 21:217–227. 2003.PubMed/NCBI
|
|
21
|
Ueda S, Yamanoi A, Hishikawa Y, Dhar DK,
Tachibana M and Nagasue N: Transforming growth factor-beta1
released from the spleen exerts a growth inhibitory effect on liver
regeneration in rats. Lab Invest. 83:1595–1603. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Akahoshi T, Hashizume M, Tanoue K, et al:
Role of the spleen in liver fibrosis in rats may be mediated by
transforming growth factor beta-1. J Gastroenterol Hepatol.
17:59–65. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Giles TD, Sander GE, Nossaman BD and
Kadowitz PJ: Impaired vasodilation in the pathogenesis of
hypertension: focus on nitric oxide, endothelial-derived
hyperpolarizing factors, and prostaglandins. J Clin Hypertens.
14:198–205. 2012. View Article : Google Scholar
|
|
24
|
Johnson RA, Kozma F and Colombari E:
Carbon monoxide: from toxin to endogenous modulator of
cardiovascular functions. Braz J Med Biol Res. 32:1–14. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Furchgott RF and Jothianandan D:
Endothelium-dependent and -independent vasodilation involving
cyclic GMP: relaxation induced by nitric oxide, carbon monoxide and
light. Blood Vessels. 28:52–61. 1991.
|
|
26
|
Decaluwe K, Pauwels B, Verpoest S and Van
de Voorde J: Divergent mechanisms involved in CO and CORM-2 induced
vasorelaxation. Eur J Pharmacol. 674:370–377. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Carter EP, Hartsfield CL, Miyazono M,
Jakkula M, Morris KG Jr and McMurtry IF: Regulation of heme
oxygenase-1 by nitric oxide during hepatopulmonary syndrome. Am J
Physiol Lung Cell Mol Physiol. 283:L346–L353. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang F, Duan ZJ and Sun YJ: Influence of
heme oxygenase-1 expression on immune liver fibrosis induced by
cobalt protoporphyrin in rats. World J Gastroenterol. 15:3009–3014.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Barikbin R, Neureiter D, Wirth J, et al:
Induction of heme oxygenase 1 prevents progression of liver
fibrosis in Mdr2 knockout mice. Hepatology. 55:553–562. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Khan ZA, Barbin YP, Cukiernik M, Adams PC
and Chakrabarti S: Heme-oxygenase-mediated iron accumulation in the
liver. Can J Physiol Pharmacol. 82:448–456. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kartikasari AE, Wagener FA, Yachie A,
Wiegerinck ET, Kemna EH and Swinkels DW: Hepcidin suppression and
defective iron recycling account for dysregulation of iron
homeostasis in heme oxygenase-1 deficiency. J Cell Mol Med.
13:3091–3102. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Crichton RR, Wilmet S, Legssyer R and Ward
RJ: Molecular and cellular mechanisms of iron homeostasis and
toxicity in mammalian cells. J Inorg Biochem. 91:9–18. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Immenschuh S, Baumgart-Vogt E and Mueller
S: Heme oxygenase-1 and iron in liver inflammation: a complex
alliance. Curr Drug Targets. 11:1541–1550. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ramm GA and Ruddell RG: Iron homeostasis,
hepatocellular injury, and fibrogenesis in hemochromatosis: the
role of inflammation in a noninflammatory liver disease. Semin
Liver Dis. 30:271–287. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Pietrangelo A: Metals, oxidative stress,
and hepatic fibrogenesis. Semin Liver Dis. 16:13–30. 1996.
View Article : Google Scholar
|
|
36
|
Deugnier Y and Turlin B: Pathology of
hepatic iron overload. Semin Liver Dis. 31:260–271. 2011.
View Article : Google Scholar
|
|
37
|
Chen YC, Gines P, Yang J, et al: Increased
vascular heme oxygenase-1 expression contributes to arterial
vasodilation in experimental cirrhosis in rats. Hepatology.
39:1075–1087. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Shi BM, Wang XY, Mu QL, Wu TH and Xu J:
Value of portal hemodynamics and hypersplenism in cirrhosis
staging. World J Gastroenterol. 11:708–711. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Valero MA, Girones N, Garcia-Bodelon MA,
et al: Anaemia in advanced chronic fasciolosis. Acta Trop.
108:35–43. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Rhyu DY, Park J, Sharma BR and Ha H: Role
of reactive oxygen species in transforming growth
factor-beta1-induced extracellular matrix accumulation in renal
tubular epithelial cells. Transplant Proc. 44:625–628. 2012.
View Article : Google Scholar
|
|
41
|
Urtasun R, Conde de la Rosa L and Nieto N:
Oxidative and nitrosative stress and fibrogenic response. Clin
Liver Dis. 12:769–790. viii2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yao P, Nussler A, Liu L, et al: Quercetin
protects human hepatocytes from ethanol-derived oxidative stress by
inducing heme oxygenase-1 via the MAPK/Nrf2 pathways. J Hepatol.
47:253–261. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Okada K, Warabi E, Sugimoto H, et al: Nrf2
inhibits hepatic iron accumulation and counteracts oxidative
stress-induced liver injury in nutritional steatohepatitis. J
Gastroenterol. 47:924–935. 2012. View Article : Google Scholar : PubMed/NCBI
|
